These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14760078)

  • 1. DNA methylation in serum and tumors of cervical cancer patients.
    Widschwendter A; Müller HM; Fiegl H; Ivarsson L; Wiedemair A; Müller-Holzner E; Goebel G; Marth C; Widschwendter M
    Clin Cancer Res; 2004 Jan; 10(2):565-71. PubMed ID: 14760078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A COMPARATIVE ANALYSIS OF METHYLATION STATUS OF TUMOR SUPPRESSOR GENES IN PAIRED BIOPSY AND SERUM SAMPLES FROM CERVICAL CANCER PATIENTS AMONG NORTH INDIAN POPULATION.
    Jha AK; Sharma V; Nikbakht M; Jain V; Sehgal A; Capalash N; Kaur J
    Genetika; 2016 Feb; 52(2):255-9. PubMed ID: 27215041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Alteration by DNA Methylation of ESR1, MYOD1 and hTERT Gene Promoters is Useful for Prediction of Response in Patients of Locally Advanced Invasive Cervical Carcinoma Treated by Chemoradiation.
    Sood S; Patel FD; Ghosh S; Arora A; Dhaliwal LK; Srinivasan R
    Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):720-7. PubMed ID: 26344356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression.
    Iliopoulos D; Oikonomou P; Messinis I; Tsezou A
    Oncol Rep; 2009 Jul; 22(1):199-204. PubMed ID: 19513524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant promoter methylation and silencing of RASSF2A gene in cervical cancer.
    Zhang X; Ma Y; Wu Y; Lin L; Ma X; Zhang Y
    J Obstet Gynaecol Res; 2014 May; 40(5):1375-81. PubMed ID: 24605823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.
    Widschwendter A; Müller HM; Hubalek MM; Wiedemair A; Fiegl H; Goebel G; Mueller-Holzner E; Marth C; Widschwendter M
    Gynecol Oncol; 2004 May; 93(2):407-16. PubMed ID: 15099954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of the MYOD1 gene is a novel prognostic factor in patients with colorectal cancer.
    Hiranuma C; Kawakami K; Oyama K; Ota N; Omura K; Watanabe G
    Int J Mol Med; 2004 Mar; 13(3):413-7. PubMed ID: 14767572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic DNA methylation marker in serum of cancer patients.
    Müller HM; Fiegl H; Widschwendter A; Widschwendter M
    Ann N Y Acad Sci; 2004 Jun; 1022():44-9. PubMed ID: 15251938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients.
    Widschwendter A; Ivarsson L; Blassnig A; Müller HM; Fiegl H; Wiedemair A; Müller-Holzner E; Goebel G; Marth C; Widschwendter M
    Int J Cancer; 2004 Mar; 109(2):163-6. PubMed ID: 14750164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
    Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D
    Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer.
    Lando M; Fjeldbo CS; Wilting SM; C Snoek B; Aarnes EK; Forsberg MF; Kristensen GB; Steenbergen RD; Lyng H
    Epigenetics; 2015; 10(10):970-80. PubMed ID: 26291246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancer.
    Müller HM; Widschwendter A; Fiegl H; Goebel G; Wiedemair A; Müller-Holzner E; Marth C; Widschwendter M
    Cancer Lett; 2004 Jun; 209(2):231-6. PubMed ID: 15159026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer.
    Zhang J; Lin Z; Gao Y; Yao T
    J Exp Clin Cancer Res; 2017 Jan; 36(1):5. PubMed ID: 28057015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant Hypermethylation of SALL3 with HPV Involvement Contributes to the Carcinogenesis of Cervical Cancer.
    Wei X; Zhang S; Cao D; Zhao M; Zhang Q; Zhao J; Yang T; Pei M; Wang L; Li Y; Yang X
    PLoS One; 2015; 10(12):e0145700. PubMed ID: 26697877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
    Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
    APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.
    Harden SV; Tokumaru Y; Westra WH; Goodman S; Ahrendt SA; Yang SC; Sidransky D
    Clin Cancer Res; 2003 Apr; 9(4):1370-5. PubMed ID: 12684406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
    Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
    Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
    Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
    Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.